THCB

Categories

Above the Fold

TikTok Teen’s Time

• 2

By KIM BELLARD

I knew about TikTok, but not “TikTok Teens.”  I was vaguely aware of K-Pop, but I didn’t know its fans had common interests beyond, you know, K-Pop.  I’d been tracking Gen X and Millennials but hadn’t really focused on Gen Z.  It turns out that these overlapping groups are quite socially aware and are starting to make their influence felt.  

I can’t wait for them to pay more attention to health care.  

This is the generation that has grown up during/in the wake of 9/11, the War on Terror, the War on Drugs, the 2008 recession, the coronavirus pandemic, and the current recession — not to mention smartphones, social media, online shopping, and streaming.  Greta Thunberg is Gen Z, as is Billie Eilish, each of whom is leading their own social movements.  This generation has a lot to protest about, and a lot of ways to do it.

They were in the news this past weekend due to, of all things, President Trump’s Tulsa rally.  His campaign had boasted about having a million people sign up for the rally, only to find that the arena was less than a third filled.  An outdoor rally for the expected overflow crowd was cancelled.  

It didn’t take long for the TikTok Teens/K-Pop fans to boast on social media about their covert — to us older folks — campaign to register for the rally as a way to gum up the campaign efforts.  Steve Schmidt, an anti-Trump Republican strategist, tweeted: “The teens of America have struck a savage blow against @realDonaldTrump.”

Continue reading…

Long-Term Telehealth Expansion Should Be Planned Intelligently

By KEN TERRY

Telehealth has been a lifeline for many doctors and patients during the pandemic, and the decisions of CMS and many private payers to cover telehealth visits—in some cases, at full parity with in-person visits–has helped physician practices stave off bankruptcy. Assuming that these policies remain in effect after the pandemic, I agree with the commentators who assert that telemedicine will become a much larger part of healthcare.

Nevertheless, what that means is still far from clear. To begin with, telehealth visits may be adequate for some purposes but not for others. Historically, the technology has been used mostly for diagnosing and treating minor acute problems. Physicians were generally reluctant to take on more complex cases or treat chronic conditions without seeing patients in person.

Pre-pandemic, most telehealth encounters took place between patients and doctors who had never treated them before, using services such as Teladoc, American Well and Doctor on Demand that usually didn’t communicate with the patients’ personal doctors. Some larger physician groups had begun to use the technology with their own patients; but even in those groups, certain doctors were often assigned to conduct virtual visits with patients who were not necessarily their own.

Clearly, the latter barrier has been broken down, with nearly half of U.S. physicians in an April survey saying they were using telemedicine in patient care. While it’s unclear what kinds of cases these doctors are diagnosing and treating, it’s likely that the scope of practice for telehealth has been expanded to include some chronic disease care.

The main barrier to this expansion is that, in telehealth encounters, physicians don’t necessarily have the data they need to make sound medical decisions. To manage hypertension, for instance, the physician needs to be able to measure a patient’s blood pressure. If the patient has a digital blood pressure cuff at home, that data can be transmitted to a physician’s office; in fact, a smartphone app could show the trend of the patient’s hypertension over time. Right now, however, only a small fraction of patients have this kind of remote monitoring equipment.

Continue reading…

USMLE Step 1 During COVID-19: A Fog of Uncertainty

Marcus Wiggins
Puneet Kaur
Pranav Puri

By PRANAV PURI, PUNEET KAUR, and MARCUS WIGGINS, MBA

As current medical students, the ongoing COVID-19 pandemic represents the most significant healthcare crisis of our lifetimes. COVID-19 has upended nearly every element of healthcare in the United States, including medical education. The pandemic has exposed shortcomings in healthcare delivery ranging from the care of nursing home residents to the lack of interoperable health data. However, the pandemic has also exposed shortcomings in the residency match process.

Consider the United States Medical Licensing Examination (USMLE) Step 1. A 2018 survey of residency program directors cited USMLE Step 1 scores as the most important factor in selecting candidates to interview. Moreover, program directors frequently apply numerical Step 1 score cutoffs to screen applicants for interviews. As such, there are marked variations in mean Step 1 scores across clinical specialties. For example, in 2018, US medical graduates who matched into neurosurgery had a mean Step 1 scores of 245, while those matching into neurology had a mean Step 1 score of 231.

One would assume that, at a minimum, Step 1 scores are a standardized, objective measure to statistically distinguish applicants. Unfortunately, this does not hold true. In its score interpretation guidelines, the National Board of Medical Examiners (NBME) provides Step 1’s standard error of difference (SED) as an index to determine whether the difference between two scores is statistically meaningful.  The NBME reports a SED of 8 for Step 1. Assuming Step 1 scores are normally distributed, the 95% confidence interval of a Step 1 score can thus be estimated as the score plus or minus 1.96 times the standard error (Figure 1). For example, consider Student A who is interested in pursuing neurosurgery and scores 231. The 95% confidence interval of this score would span from 215 to 247. Now consider Student B who is also interested in neurosurgery and scores 245. The 95% interval of this score would span from 229 to 261. The confidence intervals of these two scores clearly overlap, and therefore, there is no statistically significant difference between Student A and Student B’s exam performance. If these exam scores represented the results of a clinical trial, we would describe the results as null and dismiss the difference in scores as mere chance.

Continue reading…

Omada Health’s Acquisition of Physera: Sean Duffy & Dan Rubinstein on ‘The Deal’ & What’s Next

By JESSICA DaMASSA, WTF HEALTH

Omada Health put to use part of their recent $57M funding round to acquire Physera, a musculoskeletal care company that uses telehealth and digital interventions to deliver ‘virtual physical therapy’ to those suffering from back, knee, and neck pain. How does the acquisition fit into Omada’s growth strategy? WTF Health’s Jessica DaMassa chats with both Omada Health’s CEO, Sean Duffy, and Dan Rubinstein, CEO of Physera, about the acquisition, the IPO buzz that continues to swirl around Omada, and whether or not the opportunity that COVID-19 has created for digital care will be lasting as we move forward.

Health in 2 Point 00, Episode 129 | Kaia Health, RapidSOS, Abacus Insights, Ready, and Doximity

• 1

Today on Health in 2 Point 00, we have more deals to cover continuing off of yesterday’s episode! Jess and I talk about Kaia Health raising $26 million in a B round led by Optum Ventures, RapidSOS gets $21 million for their emergency response tech, Abacus Insights raising $35 million, and Ready raising $48 million pairing home visits from EMTs and nurses with telehealth. In other news, Target is now offering free access to telehealth visits through CirrusMD, and Doximity is acquiring THMED (which is changing its name to Curative) to put together a database of doctors to improve healthcare staffing/recruitment. —Matthew Holt

Three Things I Hope Health Care Won’t Recover From

• 1

By RANDY CARPENTER

The loss of lives and livelihoods from COVID-19 are almost too much to comprehend. And yet, slowly, conversations are emerging about the positives percolating from the pandemic.

It’s human nature to want to look for the positives in even the worst of situations, and I’ve noticed that in both my personal and my professional circles of late, people are talking about the things they hope we don’t lose when things go back to “normal.” 

Chief among them, especially in my healthcare technology circles, is a level of humanity that our previously faster-paced lives, ways and organizations had perhaps too often and too easily dismissed. The humans on the frontline of care delivery, for example. The effects of social isolation on healthy people, much less those who are sick. The struggle and juggle of modern work-life balance. Inequalities in healthcare access and delivery.

We’ve long talked about technology’s ability to make some of these things easier, to close some of these gaps, but now we know just how possible they are when people, politics and policy unite in the face of a pandemic. We now know just how quickly even the largest and slowest-moving of health systems can change course and even course correct.

Until now, it’s been far easier to talk about the promise of technology, telemedicine and remote workforce scenarios than it was to actually deploy them. Because before, to deploy such solutions also meant loss; loss of control, loss of normalcy, loss of humanity. Until now.

Continue reading…

THCB Gang, Episode 14

Episode 14 of “The THCB Gang” was live-streamed on Thursday, June 18th. Tune in below!

Joining Matthew Holt were four regulars: health futurist Ian Morrison (@seccurve), writer Kim Bellard (@kimbbellard), MD turned leadership coach Maggi Cary (@MargaretCaryMD), Consumer advocate & CTO of Carium Health Lygeia Ricciardi (@Lygeia), and two guests: Emergency Room MD, IT consultant and so much more Medell Briggs (MedellBriggsMD), and patient advocate CEO of Patient Orator, Kistein Monkhouse (@KisteinM). It was a very thoughtful conversation about patient care, the role of social movements, what to do about structural racism in health care, and what new legislation might come from the federal level. You can watch below right now.

If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

Health in 2 Point 00, Episode 128 | Proteus, Walmart, Kyruus, Headspace and CareAcademy

On Episode 128 of Health in 2 Point 00, Jess and I talk about Proteus filing for bankruptcy, Walmart buying the tech from CareZone for prescription drug management for an unconfirmed $200 million, Kyruus raising another $30 million for referrals and scheduling for large health systems, Headspace raising another $47.7 million, and CareAcademy raising $9.5 million in a Series A to provide online training for professional caregivers for seniors. —Matthew Holt

Your Face is Not Your Own

By KIM BELLARD

I swear I’d been thinking about writing about facial recognition long before I discovered that John Oliver devoted his show last night to it.  Last week I wrote about how “Defund Police” should be expanded to “Defund Health Care,” and included a link to Mr. Oliver’s related episode, only to have a critic comment that I should have just given the link and left it at that.  

Now, I can’t blame anyone for preferring Mr. Oliver’s insights to mine, so I’ll link to his observations straightaway…but if you’re interested in some thoughts about facial recognition and healthcare, I hope you’ll keep reading.

Facial recognition is, indeed, in the news lately, and not in a good way.  Its use, particularly by law enforcement agencies, has become more widely known, as have some of its shortcomings.  At best, it is still weak at accurately identifying minority faces (or women), and at worst it poses significant privacy concerns for, well, everyone.  The fact that someone using such software could identify you in a crowd using publicly available photographs, and then track your past and subsequent movements, is the essence of Big Brother.  

Continue reading…

THCB Spotlights: Allison Martin, UDoTest and Rahul Dubey, AHIP

This is one of the more unusual videos I’ve done as a THCB Spotlight. I’ve been advising Allison Martin at UDoTest for a while. Meanwhile, I met Rahul Dubey when he was running innovation at AHIP. Then I saw his name all over Twitter and everywhere else because he had let a large number of protesters into his house as the police violently broke up a BLM protest earlier this month. What I didn’t know was how well they knew each other, but I got them together late last week and it made for a fascinating conversation about society, health care, and the future. —Matthew Holt

assetto corsa mods